The Latest News On New Clinical Trials and Industry Deals

Awards & Advancement

Prev 10 21 22 23 24 25 26 27 28 29 30 Next 10

Rempex raises $67.5 million in Series B financing

Wednesday, November 9, 2011 02:06 PM

Rempex Pharmaceuticals has completed the initial closing of a Series B financing. New investors Frazier Healthcare Ventures and Vivo Ventures joined existing investors SV Life Sciences, OrbiMed Advisors and Adams Street Partners in committing to a total of $67.5 million for this round. This financing, together with a previous Series A round, brings the total financing commitment for Rempex to $76 million since the company's founding in June 2011.

More... »

Rhythm names CEO

Wednesday, November 9, 2011 08:34 AM

Rhythm, a biotechnology company, has named Keith M. Gottesdiener, MD, chief executive officer.

More... »

Hoffman joins Theorem Clinical Research

Tuesday, November 8, 2011 03:35 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Marc Hoffman, MD, senior vice president and general manager for their newly formed pharmaceutical development business unit. In his new role, Hoffman will have strategic oversight for Theorem’s core CRO operation, including project management, clinical monitoring, SMART (site management and patient recruitmenT), and pharmaceutics. He will also oversee the company’s medical operations.

More... »

Dendreon names Fenton to board of directors

Tuesday, November 8, 2011 10:12 AM

Dendreon has named Dennis M. Fenton to the board of directors, effective November 8, 2011.

More... »

Advanced Clinical names director of clinical operations

Monday, November 7, 2011 11:19 AM

Advanced Clinical has named Michaelene Lewand director of clinical operations to lead its expansion of service offerings.

More... »

Crane joins SNBL USA

Monday, November 7, 2011 10:47 AM

SNBL USA has named Mark T. Crane vice president of business development. Crane will have overall responsibility for the company’s marketing, sales and business development efforts and will be tasked with driving the growth of SNBL USA's business model and fostering positive relationships with new and current customers.

More... »

ICON named clinical research team of the year

Monday, November 7, 2011 10:10 AM

ICON has won the clinical research team of the year award at the annual 2011 Scrip Awards.

More... »

NanoString raises $20 million in Series D financing

Monday, November 7, 2011 09:52 AM

NanoString Technologies, a privately held provider of life science tools for translational research and developer of molecular diagnostics, has closed $20 million in a Series D round of equity financing. New investors include GE, BioMed Ventures and Henri Termeer, former chairman and CEO of Genzyme. All previous venture investors in NanoString also participated in the financing, including Clarus Ventures, Draper Fisher Jurvetson and OVP Venture Partners.

More... »

Scrip names PPD best CRO

Friday, November 4, 2011 11:43 AM

PPD has been named the best contract research organization by Scrip Intelligence, which also has honored PPD for deploying the best technological development in clinical trials.

More... »

Quin joins Asymchem as VP, medicinal chemistry

Thursday, November 3, 2011 01:31 PM

Asymchem Life Science has named Dr. Li Qun vice president of medicinal chemistry. His responsibilities include managing FTE work in medicinal and preclinical synthetic chemistry, based out of TEDA Tianjin.

More... »